✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹927 Cr.
P/E
21.11
  • Wanbury
  • Shivalik Rasayan
  • Anuh Pharma
FAQs on Wanbury Ltd. Shareprice

Wanbury has given better returns compared to its competitors.
Wanbury has grown at ~50.8% over the last 3yrs while peers have grown at a median rate of 16.51%

Yes, Wanbury is expensive.
Latest PE of Wanbury is 21.11, while 3 year average PE is 12.99.
Also latest EV/EBITDA of Wanbury is 17.29 while 3yr average is 13.03.

Growth Table
  • Wanbury Ltd.
  • Shivalik Rasayan
  • Anuh Pharma
Balance Sheet
  • Wanbury Ltd.
  • Shivalik Rasayan
  • Anuh Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Wanbury Ltd.
  • Shivalik Rasayan
  • Anuh Pharma
Cash Flow
  • Wanbury Ltd.
  • Shivalik Rasayan
  • Anuh Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Wanbury Ltd.
  • Shivalik Rasayan
  • Anuh Pharma
Quarterly Results
  • Wanbury Ltd.
  • Shivalik Rasayan
  • Anuh Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Wanbury Ltd. Financials

Balance sheet of Wanbury is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Wanbury is increasing.
Latest debt of Wanbury is ₹164 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹98.28 Crs.

The profit is oscillating.
The profit of Wanbury is ₹43.91 Crs for TTM, ₹55.96 Crs for Mar 2024 and -₹10.4 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Wanbury latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech